Torrent Pharmaceuticals announced the release of its presentation materials for analysts covering the unaudited Consolidated Financial Results for the quarter and nine months ending December 31, 2025. Key highlights show robust performance, with consolidated revenues growing 18% year-over-year for the quarter. India remains the largest segment, contributing ₹1,798 crore in Q3 FY26, alongside significant growth observed in markets like Brazil (27%) and the US (19%).
Financial Results Disclosure for Q3 FY 2025-26
Torrent Pharmaceuticals has formally submitted the presentation materials detailing its unaudited Consolidated Financial Results for the third quarter and the nine months ended 31st December, 2025. This information is being provided to analysts for review and discussion following the formal announcement.
Q3 FY26 Quarterly Revenue Performance (Rs cr)
The company reported strong aggregate growth for the quarter ending December 2025, with total revenues reaching ₹3,303 crore, marking a significant increase of 18% compared to the ₹2,809 crore reported in Q3 FY25.
Segmental revenue highlights for Q3 FY26 compared to Q3 FY25:
| Region | Q3 FY26 (Rs cr) | Q3 FY25 (Rs cr) | Growth (%) |
|---|---|---|---|
| India | 1798 | 1581 | 14% |
| United States | 321 | 271 | 19% |
| Germany | 304 | 282 | 8% |
| Brazil | 371 | 291 | 27% |
| Others | 509 | 384 | 32% |
| Total | 3303 | 2809 | 18% |
Year-to-Date (YTD) Financial Overview (Rs cr)
For the nine months ended December 2025, Torrent Pharma achieved total revenues of ₹9,783 crore, an improvement of 14% over the corresponding period last year (YTD Dec 24: ₹8,557 crore).
Year-to-Date revenue summary:
| Region | YTD Dec 25 (Rs cr) | YTD Dec 24 (Rs cr) | Growth (%) |
|---|---|---|---|
| India | 5430 | 4848 | 12% |
| United States | 967 | 798 | 21% |
| Germany | 916 | 853 | 7% |
| Brazil | 907 | 750 | 21% |
| Others | 1563 | 1308 | 20% |
| Total | 9783 | 8557 | 14% |
Conclusion
The submission, dated 13th February, 2026, contains the comprehensive presentation materials that management will use when discussing the company’s financial performance, highlighting strong growth momentum across key international markets, particularly Brazil and the United States.
Source: BSE
